. Schematic of experimental design used in this study showing the medium used for each set of experiments, the number of replicates, the analyses that these samples were used for and the figures that these data led to. For the enrichment, isolation, screening and selection of isolates and characterization of two isolates, six plasticizers were used: dibutyl phthalate (DBP), bis(2-ethyl hexyl) phthalate (DEHP), diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), acetyl tributyl citrate (ATBC) and trioctyl trimellitate (TOTM; chemical structures are shown in Table 1 ). For the proteomic and metabolomic characterization, a subset of three plasticizers were chosen to further characterize the mechanisms of plasticizer degradation by these two microorganisms: DBP and DEHP, two of the most abundantly used PAE plasticizers, both with differing chain lengths and degrees of branching, and ATBC, a new non-phthalic eco-friendly plasticizer for which no biodegradation pathway has been described to date. Supplementary Fig.  S3 ) and six different plasticizers (0.1% v/v), as well as phthalate (0.02% w/v; Supplementary Fig. S4 ). Points and error bars represent the means and standard deviations, respectively, of three biological replicates. Curves for labile substrates, phthalic acid, DBP, DEHP and ATBC are as shown in Fig. 1.  Figure S6 . Catabolic pathways informed by genomic, proteomic and metabolomic analyses for DBP, DEHP and ATBC degradation by Mycobacterium sp. DBP42. Initial plasticizer substrates are shown in grey boxes, while degradation intermediates that were detected by metabolomics are shown with yellow or blue boxes if they were identified in the DBP or ATBC metabolomes, respectively. Dashed black arrows show reactions inferred by metabolomics, although no enzyme catalyzing the reaction could be confidently assigned by proteogenomics. Dashed grey arrows indicate that this substrate enters a known pathway (not detailed here). Solid arrows indicate reactions catalyzed by enzymes that were detected either in the genomes (dark grey) or proteomics (yellow). Enzyme ID number and fold change in each treatment (DBP, DEHP and ATBC vs control) is shown for each reaction. All enzymes shown here were detected in the cellular proteome, aside from the isocitrate lyase 5755 (name shown in red), which was detected in the exo-proteome. Dashed lines in chemical structures indicate uncertainty on composition. Figure S7 . Catabolic pathways informed by genomic, proteomic and metabolomic analyses for DBP, DEHP and ATBC degradation by Halomonas sp. ATBC28. Initial plasticizer substrates are shown in grey boxes, while degradation intermediates that were detected by metabolomics are shown with yellow or blue boxes if they were identified in the DBP or ATBC metabolomes, respectively. Dashed black arrows show reactions inferred by metabolomics, although no enzyme catalyzing the reaction could be confidently assigned by proteogenomics. Dashed grey arrows indicate that this substrate enters a known pathway (not detailed here). Solid arrows indicate reactions catalyzed by enzymes that were detected either in the genomes (dark grey) or proteomics (yellow). Enzyme ID number and fold change in each treatment (DBP, DEHP and ATBC vs control) is shown for each reaction for which this enzyme was found in all three biological replicates of at least one treatment. Enzymes with names shown in black were detected in the cellular proteome while those in red were detected in the exo-proteome. Dashed lines in chemical structures indicate uncertainty on composition. * denotes that this step is described in KEGG, but no enzyme capable of this reaction is currently known, while ** denotes that this step can be carried out by a Cytochrome P450 that was not detected in the genome of Halomonas sp. ATBC28. 
